Patient and Hospital Characteristics of Mitral Valve Surgery in the United States.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 11 2019
Historique:
pubmed: 3 10 2019
medline: 16 7 2020
entrez: 3 10 2019
Statut: ppublish

Résumé

Volume metrics may have relevance in the evaluation of valve center expertise. However, a paucity of data exists regarding the quantity, volume, and geographic location of mitral valve (MV) surgical centers in the United States and the proportion of underserved populations they treat. To evaluate the hospital, patient, and procedural characteristics of mitral valve repair or replacement (MVRR) in the United States as a function of hospital procedure volume. This cross-sectional, multicenter observational study was conducted from July 2014 to June 2018. Patients in the Society of Thoracic Surgeons Adult Cardiac Surgery Database undergoing any surgical procedure involving MVRR in the United States were included. Volume distribution of MVRR by hospital and hospital referral region. There were 165 405 MVRRs performed in 1082 centers during the study period, of which 86 488 (52.3%) were MV repairs. There were 575 centers (53.1%) that performed 25 or more MVRRs per year. The geographic distribution of centers performing 25 or more MVRRs per year differed from those performing fewer than 25 MVRRs per year. Of 304 designated hospital referral regions, 235 (77.3%) had at least 1 center performing 25 or more MVRRs per year, representing accessibility to 1 or more such centers for 296.4 million of 320.1 million US residents (92.6% of the US population; Midwest, 60.0 million of 68.0 million [88.4%]; South, 112.6 million of 122.6 million [91.9%]; West, 68.6 million of 72.9 million [94.1%]; and Northeast, 54.9 million of 56.6 million [97.1%]). Of 304 hospital referral regions, 168 (55.3%) had at least 1 center performing 40 or more MVRRs per year, representing accessibility to 1 or more such centers for 259.8 million of 317.90 million (81.7%) of the US population (Midwest, 50.5 million of 67.9 million [74.5%]; South, 94.5 million of 121.1 million [78.1%]; West, 64.0 million of 72.8 million [88.0%]; Northeast, 50.1 million of 56.3 million [90.2%]). More black and Hispanic patients received operations in centers performing 25 or more MVRRs per year (22 984) vs those performing fewer than 25 MVRRs per year (3227), yet the proportion was higher in lower-volume centers (22 984 of 148 385 [15.5%] vs 3227 of 17 020 [19.0%]; P < .001). In centers performing 25 or more MVRRs per year vs fewer than 25 MVRRs per year, there was a lower percentage of Medicare and Medicaid patients (47 920 of 148 385 [32.3%] vs 6183 of 17 020 [.3%]; P < .001) and patients from rural zip codes (21 208 of 148 385 [14.3%] vs 3146 of 17 020 [18.5%]; P < .001). Fifty-three percent of all centers performed 25 or more MVRRs per year, and 92.6% of the US population lived in an hospital referral region with at least 1 such center. Disparities in race/ethnicity, rurality, and insurance status exist among patients being treated at centers with different volumes. These data indicate that efforts to centralize care based on volume metrics will need to balance access vs quality.

Identifiants

pubmed: 31577335
pii: 2752377
doi: 10.1001/jamacardio.2019.3659
pmc: PMC6777237
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1149-1155

Références

J Thorac Cardiovasc Surg. 2014 Sep;148(3):995-1003; discussion 1003-4
pubmed: 25048633
JAMA. 2006 Oct 25;296(16):1973-80
pubmed: 17062860
J Am Coll Cardiol. 2017 Apr 24;:
pubmed: 28476349
Med Care. 2003 Nov;41(11):1240-55
pubmed: 14583687
N Engl J Med. 2004 Aug 5;351(6):575-84
pubmed: 15295050
Heart. 2006 Jul;92(7):939-44
pubmed: 16251225
Ann Thorac Surg. 2016 Jan;101(1):33-41; discussion 41
pubmed: 26542437
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732

Auteurs

Sreekanth Vemulapalli (S)

Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
Duke Clinical Research Institute, Durham, North Carolina.

Maria Grau-Sepulveda (M)

Duke Clinical Research Institute, Durham, North Carolina.

Robert Habib (R)

Society of Thoracic Surgeons Research Center, Chicago, Illinois.

Vinod Thourani (V)

Department of Cardiac Surgery, Medstar Heart and Vascular Institute, Georgetown University, Washington, District of Columbia.

Joseph Bavaria (J)

Division of Cardiothoracic Surgery, University of Pennsylvania, Philadelphia.

Vinay Badhwar (V)

Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH